rs1131692148
Variant names:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_181507.2(HPS5):c.1417C>T(p.Gln473*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
HPS5
NM_181507.2 stop_gained
NM_181507.2 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.60
Genes affected
HPS5 (HGNC:17022): (HPS5 biogenesis of lysosomal organelles complex 2 subunit 2) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 6 protein and may interact with the cytoplasmic domain of integrin, alpha-3. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 5. Multiple transcript variants encoding two distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-18296891-G-A is Pathogenic according to our data. Variant chr11-18296891-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 427879.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-18296891-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS5 | ENST00000349215.8 | c.1417C>T | p.Gln473* | stop_gained | Exon 12 of 23 | 1 | NM_181507.2 | ENSP00000265967.5 | ||
HPS5 | ENST00000396253.7 | c.1075C>T | p.Gln359* | stop_gained | Exon 11 of 22 | 1 | ENSP00000379552.3 | |||
HPS5 | ENST00000438420.6 | c.1075C>T | p.Gln359* | stop_gained | Exon 11 of 22 | 1 | ENSP00000399590.2 | |||
HPS5 | ENST00000531848.1 | c.1075C>T | p.Gln359* | stop_gained | Exon 11 of 11 | 5 | ENSP00000431758.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hermansky-Pudlak syndrome 5 Pathogenic:2
Mar 14, 2017
Laboratoire de Génétique Moléculaire, CHU Bordeaux
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Jan 25, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Pathogenic:1
Feb 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at